|
|
|
|
LEADER |
01897nam a22003375i 4500 |
001 |
000288493 |
005 |
20210831110858.0 |
007 |
cr nn 008mamaa |
008 |
150512s2015 gw | s |||| 0|eng d |
020 |
|
|
|a 9783319136110
|
024 |
7 |
|
|a 10.1007/978-3-319-13611-0
|2 doi
|
040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
245 |
1 |
0 |
|a Nitric Oxide and Cancer: Pathogenesis and Therapy /
|c edited by Benjamin Bonavida.
|
250 |
|
|
|a 1st ed. 2015.
|
260 |
# |
# |
|a Cham :
|b Springer International Publishing :
|b Imprint: Springer,
|c 2015.
|
300 |
|
|
|a XXIII, 308 p. 46 illus., 33 illus. in color. :
|b online resource.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
505 |
0 |
|
|a Inflammation-associated Carcinogenesis Involved Interaction Between with iNOS/NO and WNT/beta-catenin -- NO and Genomic Stability -- Targeting Hyponitroxia in Cancer Therapy -- Mechanism of NO-dependent Regulation of Invasion and Metastasis -- NO Role in Protumorigenesis and Hypoxia -- Impacts of S-nitrosylation in Cancer -- S-nitrosylation of Cancer Cells -- Role of S-nitrosylation in Cancer Metastasis -- NO Immunity and Cancer -- Regulation of Anti-tumor Responses by NO -- NO Immune Modulation and Tumor Growth -- Role of NO in Chemo-immune Resistance -- Emerging Role of NO-mediated Therapeutics -- PDT and NO -- Regulation of Cell Death by NO -- Discovery and Development of RRx-001 -- Nitric Oxide Coagulation and Cancer -- Neutrosphyngomyelinase 2.
|
650 |
|
0 |
|a Cancer research.
|
650 |
|
0 |
|a Molecular biology.
|
650 |
|
0 |
|a Pharmacology.
|
650 |
|
0 |
|a Drug resistance.
|
650 |
1 |
4 |
|a Cancer Research.
|
650 |
2 |
4 |
|a Molecular Medicine.
|
650 |
2 |
4 |
|a Pharmacology/Toxicology.
|
650 |
2 |
4 |
|a Drug Resistance.
|
700 |
1 |
|
|a Bonavida, Benjamin.
|e editor.
|
710 |
2 |
|
|a SpringerLink (Online service)
|
773 |
0 |
|
|t Springer eBooks
|